Randomised Controlled TrialtaVNSn = 26

Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial

Stavrakis S, Elkholey K, Morris L, Niewiadomska M, Asad ZUA, Humphrey MB

Journal of the American Heart Association · 2022

Key finding

While the early mitral inflow Doppler velocity to the early diastolic mitral annulus velocity ratio did not differ between groups, global longitudinal strain and tumor necrosis factor-α levels at 3 months were significantly improved in the active compared with the sham arm (-18.6%±2.5% versus -16...

Condition
Heart Failure
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
26
View on DOI

Cite this study

Stavrakis, S., Elkholey, K., Morris, L., Niewiadomska, M., Asad, Z. U. A., & Humphrey, M. B. (2022). Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial. Journal of the American Heart Association, 11(3). https://doi.org/10.1161/JAHA.121.023582

Related studies in Heart Failure

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.